Efficacy and Tolerability of 0.2% Thiamidol Cream for Facial Hyperpigmentation: A Randomized, Double-Blind, and Vehicle-Controlled Study
Abstract Introduction Facial hyperpigmentation is a condition that often shows limited response to treatment. Thiamidol is a proven human tyrosinase (hTyr) inhibitor. However, evidence from randomized controlled trials evaluating the effectiveness of Thiamidol in reducing facial hyperpigmentation re...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Adis, Springer Healthcare
2026-01-01
|
| Series: | Dermatology and Therapy |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1007/s13555-025-01649-y |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|